These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38258131)

  • 1. Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca
    Pachón-Angona I; Bernard PJ; Simakov A; Maj M; Jozwiak K; Novotna A; Lemke C; Gütschow M; Martin H; Oset-Gasque MJ; Contelles JM; Ismaili L
    Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment.
    Dakhlaoui I; Bernard PJ; Pietrzak D; Simakov A; Maj M; Refouvelet B; Béduneau A; Cornu R; Jozwiak K; Chabchoub F; Iriepa I; Martin H; Marco-Contelles J; Ismaili L
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels.
    Pachòn Angona I; Daniel S; Martin H; Bonet A; Wnorowski A; Maj M; Jóźwiak K; Silva TB; Refouvelet B; Borges F; Marco-Contelles J; Ismaili L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32183349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca
    Malek R; Simakov A; Davis A; Maj M; Bernard PJ; Wnorowski A; Martin H; Marco-Contelles J; Chabchoub F; Dallemagne P; Rochais C; Jozwiak K; Ismaili L
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of new Hantzsch adducts showing Ca
    Pachón-Angona I; Maj M; Wnorowski A; Martin H; Jóźwiak K; Ismaili L
    Future Med Chem; 2021 Oct; 13(20):1717-1729. PubMed ID: 34402661
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives.
    Pachón Angona I; Martin H; Daniel S; Moraleda I; Bonet A; Wnorowski A; Maj M; Jozwiak K; Iriepa I; Refouvelet B; Marco-Contelles J; Ismaili L
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapy.
    Malek R; Maj M; Wnorowski A; Jóźwiak K; Martin H; Iriepa I; Moraleda I; Chabchoub F; Marco-Contelles J; Ismaili L
    Bioorg Chem; 2019 Oct; 91():103205. PubMed ID: 31446330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (±)-
    Ismaili L; Monnin J; Etievant A; Arribas RL; Viejo L; Refouvelet B; Soukup O; Janockova J; Hepnarova V; Korabecny J; Kucera T; Jun D; Andrys R; Musilek K; Baguet A; García-Frutos EM; De Simone A; Andrisano V; Bartolini M; de Los Ríos C; Marco-Contelles J; Haffen E
    ACS Chem Neurosci; 2021 Apr; 12(8):1328-1342. PubMed ID: 33797877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-target-directed ligands in Alzheimer's disease treatment.
    Bajda M; Guzior N; Ignasik M; Malawska B
    Curr Med Chem; 2011; 18(32):4949-75. PubMed ID: 22050745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation.
    Remya C; Dileep KV; Koti Reddy E; Mantosh K; Lakshmi K; Sarah Jacob R; Sajith AM; Jayadevi Variyar E; Anwar S; Zhang KYJ; Sadasivan C; Omkumar RV
    Comput Struct Biotechnol J; 2021; 19():4517-4537. PubMed ID: 34471497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease.
    Unzeta M; Esteban G; Bolea I; Fogel WA; Ramsay RR; Youdim MB; Tipton KF; Marco-Contelles J
    Front Neurosci; 2016; 10():205. PubMed ID: 27252617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer's disease.
    Wenzel TJ; Klegeris A
    Life Sci; 2018 Aug; 207():314-322. PubMed ID: 29940242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
    Jalili-Baleh L; Forootanfar H; Küçükkılınç TT; Nadri H; Abdolahi Z; Ameri A; Jafari M; Ayazgok B; Baeeri M; Rahimifard M; Abbas Bukhari SN; Abdollahi M; Ganjali MR; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2018 May; 152():600-614. PubMed ID: 29763808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of fused hybrids with acetylcholinesterase inhibiting and Nrf2 activating functions for Alzheimer's disease.
    Wang Y; Xiong B; Lin H; Li Q; Yang H; Qiao Y; Li Q; Xu Z; Lyu W; Qu W; Liu W; Chen Y; Feng F; Sun H
    Eur J Med Chem; 2022 Dec; 244():114806. PubMed ID: 36223681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer's disease.
    Qu L; Ji L; Wang C; Luo H; Li S; Peng W; Yin F; Lu D; Liu X; Kong L; Wang X
    Eur J Med Chem; 2021 Jul; 219():113441. PubMed ID: 33862517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel multitarget-directed ligands targeting acetylcholinesterase and σ
    Lalut J; Santoni G; Karila D; Lecoutey C; Davis A; Nachon F; Silman I; Sussman J; Weik M; Maurice T; Dallemagne P; Rochais C
    Eur J Med Chem; 2019 Jan; 162():234-248. PubMed ID: 30447434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of effective phosphodiesterase 2 inhibitors with antioxidant activities for the treatment of Alzheimer's disease.
    Jiang MY; Han C; Zhang C; Zhou Q; Zhang B; Le ML; Huang MX; Wu Y; Luo HB
    Bioorg Med Chem Lett; 2021 Jun; 41():128016. PubMed ID: 33838306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel vanillin derivatives: novel multi-targeted scaffold ligands against Alzheimer's disease.
    Scipioni M; Kay G; Megson IL; Kong Thoo Lin P
    Medchemcomm; 2019 May; 10(5):764-777. PubMed ID: 31191867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.
    Meena P; Nemaysh V; Khatri M; Manral A; Luthra PM; Tiwari M
    Bioorg Med Chem; 2015 Mar; 23(5):1135-48. PubMed ID: 25624107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease.
    Sang Z; Song Q; Cao Z; Deng Y; Zhang L
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):69-85. PubMed ID: 34894968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.